Cardlytics Inc CDLX.OQ reported quarterly adjusted earnings of 3 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported breakeven earnings per share. The mean expectation of four analysts for the quarter was for a loss of 7 cents per share. Wall Street expected results to range from -10 cents to -1 cents per share.
Revenue fell 24.2% to $56.10 million from a year ago; analysts expected $54.45 million.
Cardlytics Inc's reported EPS for the quarter was a loss of 15 cents.
The company reported a quarterly loss of $8.25 million.
Cardlytics Inc shares had fallen by 27.9% this quarter.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 30% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 4 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the software peer group is "buy."
Wall Street's median 12-month price target for Cardlytics Inc is $1.50, about 40% above its last closing price of $0.90
This summary was machine generated from LSEG data March 4 at 10:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Dec. 31 2025 | -0.07 | 0.03 | Beat |
Sep. 30 2025 | -0.15 | -0.07 | Beat |
Jun. 30 2025 | -0.16 | -0.13 | Beat |
Mar. 31 2025 | -0.23 | -0.21 | Beat |
Comments